# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-23-035133
Filing Date
2023-07-27
Accepted
2023-07-27 16:06:59
Documents
34
Period of Report
2023-07-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | eypt-20230727.htm iXBRL | 8-K | 56269
2 | EX-99.1 | eypt-ex99_1.htm | EX-99.1 | 30607
3 | EX-99.2 | eypt-ex99_2.htm | EX-99.2 | 15593
4 | GRAPHIC | img96707757_0.jpg | GRAPHIC | 5406
5 | GRAPHIC | eypt-ex99_2s1.jpg | GRAPHIC | 473857
6 | GRAPHIC | eypt-ex99_2s2.jpg | GRAPHIC | 986680
7 | GRAPHIC | eypt-ex99_2s3.jpg | GRAPHIC | 449582
8 | GRAPHIC | eypt-ex99_2s4.jpg | GRAPHIC | 158349
9 | GRAPHIC | eypt-ex99_2s5.jpg | GRAPHIC | 357997
10 | GRAPHIC | eypt-ex99_2s6.jpg | GRAPHIC | 361921
11 | GRAPHIC | eypt-ex99_2s7.jpg | GRAPHIC | 159108
12 | GRAPHIC | eypt-ex99_2s8.jpg | GRAPHIC | 362677
13 | GRAPHIC | eypt-ex99_2s9.jpg | GRAPHIC | 354192
14 | GRAPHIC | eypt-ex99_2s10.jpg | GRAPHIC | 278162
15 | GRAPHIC | eypt-ex99_2s11.jpg | GRAPHIC | 219603
16 | GRAPHIC | eypt-ex99_2s12.jpg | GRAPHIC | 386853
17 | GRAPHIC | eypt-ex99_2s13.jpg | GRAPHIC | 382058
18 | GRAPHIC | eypt-ex99_2s14.jpg | GRAPHIC | 385672
19 | GRAPHIC | eypt-ex99_2s15.jpg | GRAPHIC | 191696
20 | GRAPHIC | eypt-ex99_2s16.jpg | GRAPHIC | 405502
21 | GRAPHIC | eypt-ex99_2s17.jpg | GRAPHIC | 341700
22 | GRAPHIC | eypt-ex99_2s18.jpg | GRAPHIC | 357778
23 | GRAPHIC | eypt-ex99_2s19.jpg | GRAPHIC | 250585
| Complete submission text file | 0000950170-23-035133.txt |  | 9689327

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
24 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | eypt-20230727_lab.xml | EX-101.LAB | 12806
25 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | eypt-20230727_pre.xml | EX-101.PRE | 9457
26 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | eypt-20230727.xsd | EX-101.SCH | 2475
28 | EXTRACTED XBRL INSTANCE DOCUMENT | eypt-20230727_htm.xml | XML | 4523

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 231118441
SIC: 3826 Laboratory Analytical Instruments